Markets & Regulations

(ClaudioVentrella/iStock via Getty Images Plus)

Breaking FDA COVID-19 news

By Jenni Spinner

The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.

Current FDA COVID-19 news

Current FDA COVID-19 news

By Jenni Spinner

The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.

(Isabela Maia Studio/iStock via Getty Images Plus)

This week's FDA COVID-19 news

By Jenni Spinner

The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments

(monsitj/iStock via Getty Images Plus)

People on the Move: August 2020

By Jenni Spinner

This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.

(wildpixel/iStock via Getty Images Plus)

Most recent FDA COVID-19 updates

By Jenni Spinner

The US agency continues to put out informational resources, issue EUAs for tests and treatments, and monitor industry activity related to the virus.

(Image: Eastman Kodak)

Kodak Pharmaceuticals lands $765m US loan

By Jenni Spinner

The imaging company’s newly launched division, created to produce drug ingredients, received the loan from the US International Development Finance Corp.

(bennymarty/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The US agency continues releasing resources, offering advice and taking actions related to the pandemic, and how life-sciences professionals respond.

(HAKINMHAN/iStock via Getty Images Plus)

Latest FDA advice and actions on COVID-19

By Jenni Spinner

As the virus behind the pandemic continues to impact the globe, the federal agency continues to offer advice and take action in response to the virus.

(gilz/iStock via Getty Images Plus)

Weekly FDA COVID-19 updates and actions

By Jenni Spinner

The agency continues to offer advice to pharma industry professionals during the global public health crisis, and offer advice on developing solutions.

Follow us

Products

View more

Webinars